These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 8558003)

  • 1. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
    Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
    J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18).
    Xia Y; Ross GD
    J Immunol; 1999 Jun; 162(12):7285-93. PubMed ID: 10358177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.
    Galon J; Gauchat JF; Mazières N; Spagnoli R; Storkus W; Lötze M; Bonnefoy JY; Fridman WH; Sautès C
    J Immunol; 1996 Aug; 157(3):1184-92. PubMed ID: 8757624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface receptors of neutrophils towards B. burgdorferi.
    Cinco M; Murgia R; Perticarari S; Presani G
    Wien Klin Wochenschr; 1998 Dec; 110(24):866-9. PubMed ID: 10048167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes.
    Elstad MR; Parker CJ; Cowley FS; Wilcox LA; McIntyre TM; Prescott SM; Zimmerman GA
    J Immunol; 1994 Jan; 152(1):220-30. PubMed ID: 7902855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion.
    Xia Y; Borland G; Huang J; Mizukami IF; Petty HR; Todd RF; Ross GD
    J Immunol; 2002 Dec; 169(11):6417-26. PubMed ID: 12444150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
    Vetvicka V; Thornton BP; Ross GD
    J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions.
    Zhou M; Todd RF; van de Winkel JG; Petty HR
    J Immunol; 1993 Apr; 150(7):3030-41. PubMed ID: 7681086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.
    Stöckl J; Majdic O; Pickl WF; Rosenkranz A; Prager E; Gschwantler E; Knapp W
    J Immunol; 1995 May; 154(10):5452-63. PubMed ID: 7730647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).
    Vetvicka V; Thornton BP; Wieman TJ; Ross GD
    J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
    Orchekowski RP; Plescia J; Altieri DC; Bajt ML
    J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/CD18) regulate ligand avidity and the internalization of occupied receptors.
    Rabb H; Michishita M; Sharma CP; Brown D; Arnaout MA
    J Immunol; 1993 Jul; 151(2):990-1002. PubMed ID: 8101539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18).
    Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP
    J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-glucan affects leukocyte navigation in a complex chemotactic gradient.
    Tsikitis VL; Albina JE; Reichner JS
    Surgery; 2004 Aug; 136(2):384-9. PubMed ID: 15300205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
    Xue W; Kindzelskii AL; Todd RF; Petty HR
    J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.